Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The presence and variant allele fraction of EGFR mutations in ctDNA and development of resistance

20 Mar 2019

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Genomics and Diagnostics
Share to Lung Cancer Research Studies
Share to Lung Cancer Treatments and Mutations

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 31027703
DOI: 10.1016/j.lungcan.2019.03.019

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The presence and variant allele fraction of EGFR mutations in ctDNA and development of resistancePMID 31027703Read ↗

Dynamics of circulating tumor DNA represented by the activating and resistant mutations in epidermal growth factor receptor tyrosine kinase inhibitor treatmentSemantic proximity Read ↗

Allele frequency and proportion defined by circulating tumor DNA profiling predict tyrosine kinase inhibitors' therapeutic outcomes for non-small cell lung cancer.Semantic proximity Read ↗

Early Detection of Multiple Resistance Mechanisms by ctDNA Profiling in a Patient With EGFR-mutant Lung Adenocarcinoma Treated With Osimertinib.Semantic proximity Read ↗

134O_PR: Plasma ctDNA analysis for detection of EGFR T790M mutation in patients (pts) with EGFR mutation-positive advanced non-small cell lung cancer (aNSCLC)Semantic proximity Read ↗

Genomic landscape of entrectinib resistance from ctDNA analysis in STARTRK-2Semantic proximity Read ↗

Clinical significance of gene mutation in ctDNA analysis for hormone receptor-positive metastatic breast cancerSemantic proximity Read ↗

BRAF variant allele fraction-A predictor of response to targeted therapy?Semantic proximity Read ↗

Does EGFR targeted therapy change the natural history of EGFR mutant status?Semantic proximity Read ↗

The content of mutant EGFR DNA correlates with response to EGFR-TKIs in lung adenocarcinoma patients with common EGFR mutations.Semantic proximity Read ↗

ctDNA guides anti-EGFR rechallenge.Semantic proximity Read ↗

Cancer and mutant DNA in blood plasma.Semantic proximity Read ↗

Quantification of concentration and assessment of EGFR mutation in circulating DNA.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.